News (ZH) - Moves strengthen existing analytical and bioanalytical drug development service offering
News (ZH) - The new labs comprise additional bioanalysis and synthetic chemistry labs as well as a new GMP CMC analytical capability for batch release testing of oligonucleotide-based drug substances
News (ZH) - LGC is expanding its Bioanalytical and CMC analytical services capacity at its site in Fordham, Cambridgeshire.
News (ZH) - LGC is helping customers to identify and quantify the compounds present in those components in direct contact with a drug product or patient
News (ZH) - This was the laboratory’s first inspection by the FDA and was an extensive audit focusing on GMP compliance.
News (ZH) - This new service enables continuous recording and monitoring of essential data on the impact of environmental factors, such as temperature and humidity, on the quality of a pharmaceutical product
News (ZH) - The cGMP service is an extension to the existing cell-based assay capability that LGC’s experienced team offer for biopharmaceutical development
News (ZH) - The Princess Royal was given a tour of LGC’s recently-expanded laboratories and met with scientists and apprentices to hear how the company’s cutting-edge analytical science supports doping and medication control in animal sports, provides assurance to athletes taking supplements, and helps develop new drugs and therapies
News (ZH) - Site will be dedicated to medium to large scale and early to late Phase Clinical GMP manufacturing of Nucleic Acid Therapeutics